142 related articles for article (PubMed ID: 12450225)
1. Hyperhomocyst(e)inemia: a risk factor for cerebrovascular disease.
Parnetti L; Caso V; Amici S; Lanari A; Gallai V; Bottiglieri T
Clin Exp Hypertens; 2002; 24(7-8):501-9. PubMed ID: 12450225
[TBL] [Abstract][Full Text] [Related]
2. Hyperhomocyst(e)inemia and the prevalence of atherosclerotic vascular disease in patients with end-stage renal disease.
Manns BJ; Burgess ED; Hyndman ME; Parsons HG; Schaefer JP; Scott-Douglas NW
Am J Kidney Dis; 1999 Oct; 34(4):669-77. PubMed ID: 10516348
[TBL] [Abstract][Full Text] [Related]
3. Hyperhomocyst(e)inemia is a risk factor of secondary vascular events in stroke patients.
Del Ser T; Barba R; Herranz AS; Seijas V; López-Manglano C; Domingo J; Pondal M
Cerebrovasc Dis; 2001 Aug; 12(2):91-8. PubMed ID: 11490102
[TBL] [Abstract][Full Text] [Related]
4. Hyperhomocyst(e)inemia and risk of ischemic stroke among young Asian adults.
Tan NC; Venketasubramanian N; Saw SM; Tjia HT
Stroke; 2002 Aug; 33(8):1956-62. PubMed ID: 12154245
[TBL] [Abstract][Full Text] [Related]
5. Plasma concentration of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, is elevated in monkeys with hyperhomocyst(e)inemia or hypercholesterolemia.
Böger RH; Bode-Böger SM; Sydow K; Heistad DD; Lentz SR
Arterioscler Thromb Vasc Biol; 2000 Jun; 20(6):1557-64. PubMed ID: 10845872
[TBL] [Abstract][Full Text] [Related]
6. Asymmetric dimethyl-L-arginine (ADMA): a possible link between homocyst(e)ine and endothelial dysfunction.
Stühlinger MC; Stanger O
Curr Drug Metab; 2005 Feb; 6(1):3-14. PubMed ID: 15720202
[TBL] [Abstract][Full Text] [Related]
7. Hyperhomocyst(e)inemia--determining factors and treatment.
Genest J
Can J Cardiol; 1999 Apr; 15 Suppl B():35B-38B. PubMed ID: 10350684
[TBL] [Abstract][Full Text] [Related]
8. Hyperhomocyst(e)inemia is an important risk factor for vascular disease in subjects with high-molecular weight apo(a) isoforms.
Delport R; Lingenhel AW; Ubbink JB; Kraft HG
Cardiovasc J S Afr; 2004; 15(5):207-13. PubMed ID: 15483732
[TBL] [Abstract][Full Text] [Related]
9. Hyperhomocyst(e)inemia and the increased risk of venous thromboembolism: more evidence from a case-control study.
Langman LJ; Ray JG; Evrovski J; Yeo E; Cole DE
Arch Intern Med; 2000 Apr; 160(7):961-4. PubMed ID: 10761961
[TBL] [Abstract][Full Text] [Related]
10. Hyperhomocyst(e)inemia and MTHFR C677T genotypes in patients with central retinal vein occlusion.
Weger M; Stanger O; Deutschmann H; Temmel W; Renner W; Schmut O; Semmelrock J; Haas A
Graefes Arch Clin Exp Ophthalmol; 2002 Apr; 240(4):286-90. PubMed ID: 11981642
[TBL] [Abstract][Full Text] [Related]
11. Moderate hyperhomocyst(e)inemia is associated with the presence of coronary artery disease and the severity of coronary atherosclerosis in Koreans.
Yoo JH; Park JE; Hong KP; Lee SH; Kim DK; Lee WR; Park SC
Thromb Res; 1999 Apr; 94(1):45-52. PubMed ID: 10213180
[TBL] [Abstract][Full Text] [Related]
12. Elevated plasma homocyst(e)ine concentration as a possible independent risk factor for stroke.
Coull BM; Malinow MR; Beamer N; Sexton G; Nordt F; de Garmo P
Stroke; 1990 Apr; 21(4):572-6. PubMed ID: 2326839
[TBL] [Abstract][Full Text] [Related]
13. Homocyst(e)ine and coronary artery disease. Clinical evidence and genetic and metabolic background.
Moghadasian MH; McManus BM; Frohlich JJ
Arch Intern Med; 1997 Nov; 157(20):2299-308. PubMed ID: 9361570
[TBL] [Abstract][Full Text] [Related]
14. Vascular dysfunction in hyperhomocyst(e)inemia. Implications for atherothrombotic disease.
Stanger O; Weger M; Renner W; Konetschny R
Clin Chem Lab Med; 2001 Aug; 39(8):725-33. PubMed ID: 11592442
[TBL] [Abstract][Full Text] [Related]
15. Hyperhomocyst(e)inemia and Chlamydia pneumoniae IgG seropositivity in patients with coronary artery disease.
Stanger OH; Semmelrock HJ; Rehak P; Tiran B; Meinitzer A; Rigler B; Tiran A
Atherosclerosis; 2002 May; 162(1):157-62. PubMed ID: 11947909
[TBL] [Abstract][Full Text] [Related]
16. Homocysteine as a novel risk factor for atherosclerosis.
Guthikonda S; Haynes WG
Curr Opin Cardiol; 1999 Jul; 14(4):283-91. PubMed ID: 10448607
[TBL] [Abstract][Full Text] [Related]
17. [Hyperhomocyst(e)inemia--an independent risk factor of stroke].
Lalouschek W; Aull S; Deecke L; Schnider P; Uhl F; Zeiler K
Fortschr Neurol Psychiatr; 1996 Jul; 64(7):271-7. PubMed ID: 8765893
[TBL] [Abstract][Full Text] [Related]
18. Is Hyperhomocyst(e)inemia a humoral predictor of coronary heart disease?
Virdis A; Ghiadoni L; Versari D; Salvetti G; Pinto S; Favilla S; Taddei S; Salvetti A
Curr Pharm Des; 2005; 11(17):2187-97. PubMed ID: 16026288
[TBL] [Abstract][Full Text] [Related]
19. Pathogenicity of thermolabile methylenetetrahydrofolate reductase for vascular dementia.
Yoo JH; Choi GD; Kang SS
Arterioscler Thromb Vasc Biol; 2000 Aug; 20(8):1921-5. PubMed ID: 10938012
[TBL] [Abstract][Full Text] [Related]
20. Hyperhomocyst(e)inemia induces multiorgan damage.
Miller A; Mujumdar V; Shek E; Guillot J; Angelo M; Palmer L; Tyagi SC
Heart Vessels; 2000; 15(3):135-43. PubMed ID: 11289502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
